MarketPeel
Insider Trading Intelligence
AS

Andy Sassine

ARCT
CHIEF FINANCIAL OFFICER · ARCTURUS THERAPEUTICS HOLDINGS INC. · CIK 0001515322
FILING MIX · LIFETIME86%/14%
BUYS
12
SELLS
2
TOTAL VALUE
$1.83M
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
271,764
AVG SELL PX
$31.66
TRADE KIND
SHOWING 14 / 14
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Andy Sassine, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+75.00%-0.91%-0.10%-0.81%-5.27%
14d4+75.00%+1.84%-0.67%+2.51%-12.93%
30d4+75.00%+2.33%+2.30%+0.03%-9.64%
60d4+75.00%+16.48%+2.58%+13.89%+6.17%
90d4+75.00%-33.54%+3.88%-37.42%-51.32%
180d4+75.00%+32.14%+11.04%+21.10%-60.66%
1y4(2 pending)+100.00%-25.83%+23.94%-49.77%-49.77%
2y4(2 pending)+50.00%-65.03%+31.04%-96.06%-96.06%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ARCT · 221,764 shares · as of Aug 15, 2025
068,311136,623204,934273,24520212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
FLOW · 12 buys / 2 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Financial Officer
1,238$16.56$20.5K221,764Aug 15, 2025Aug 19, 2025View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASE
Chief Financial Officer
1,238$16.56$20.5K221,764Aug 15, 2025Aug 20, 2025View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
60,00060,000Dec 16, 2024Dec 18, 2024View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Financial Officer
50,000$32.03$1.60M220,526Jun 12, 2024Jun 14, 2024View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
75,00075,000Dec 15, 2023Dec 19, 2023View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
1,223$17.37$21.2K270,526Aug 15, 2023Aug 17, 2023View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
125,000125,000Dec 9, 2022Dec 13, 2022View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
1,068$18.42$19.7K269,303Aug 15, 2022Aug 17, 2022View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
85,00085,000Jun 21, 2022Jun 23, 2022View →
XCUR
EXICURE, INC.
PURCHASEGRANT
Stock grant
50,00050,000Jun 2, 2021Jun 4, 2021View →
XCUR
EXICURE, INC.
PURCHASEGRANT
Stock grant
100,000100,000Mar 5, 2021Mar 8, 2021View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
100,000100,000Dec 18, 2020Dec 22, 2020View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASE
Chief Financial Officer
5,000$29.74$148.7K273,245Jun 10, 2020Jun 10, 2020View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
80,00080,000Feb 18, 2020Feb 20, 2020View →
Other insiders · ARCT
Loading peer insiders…
About this filer
CIK 0001515322
ROLE
Chief Financial Officer
PRIMARY
ARCT
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001515322DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback